-transparent.png){kind=logo}
We report a case of relapse of coccidioidomycosis in an HIV-infected person who discontinued maintenance azole therapy following a response to antiretroviral therapy. This experience raises concern about the safety of withholding secondary prophylaxis for coccidioidomycosis in persons with HIV infection who have achieved immunological responses to antiretroviral therapy.
Related Publications
G Mathew, and
M Smedema, and
L J Wheat, and
M Goldman
June 2006,
Infection,
G Mathew, and
M Smedema, and
L J Wheat, and
M Goldman
August 1997,
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
G Mathew, and
M Smedema, and
L J Wheat, and
M Goldman
January 2023,
IDCases,
G Mathew, and
M Smedema, and
L J Wheat, and
M Goldman
June 2015,
Medical mycology case reports,
G Mathew, and
M Smedema, and
L J Wheat, and
M Goldman
January 2017,
Internal medicine (Tokyo, Japan),
G Mathew, and
M Smedema, and
L J Wheat, and
M Goldman
October 2004,
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
G Mathew, and
M Smedema, and
L J Wheat, and
M Goldman
October 2006,
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
G Mathew, and
M Smedema, and
L J Wheat, and
M Goldman
August 2019,
International journal of STD & AIDS,
G Mathew, and
M Smedema, and
L J Wheat, and
M Goldman
January 2007,
Revista da Sociedade Brasileira de Medicina Tropical,
G Mathew, and
M Smedema, and
L J Wheat, and
M Goldman
January 2013,
Internal medicine (Tokyo, Japan),
